KERX Crosses Above Average Analyst Target
May 09, 2017 at 09:17 AM EDT
In recent trading, shares of Keryx Biopharmaceuticals Inc. (KERX) have crossed above the average analyst 12-month target price of $6.83, changing hands for $6.84/share..